Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation
Bone Marrow Transplant. 2015 Feb;50(2):315-6.
doi: 10.1038/bmt.2014.265.
Epub 2014 Nov 17.
1 1] QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia [2] Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia [3] School of Medicine, University of Queensland, Herston, Queensland, Australia [4] Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
2 Complex Systems in Biology Group, Centre for Vascular Research, UNSW Australia, Kensington, New South Wales, Australia.
3 1] Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia [2] Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
4 1] Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia [2] School of Medicine, University of Queensland, Herston, Queensland, Australia.
5 Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
6 QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.